Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Halimi

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Diabetes & Metabolism|February 14, 2007
Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes managementS Halimi
Diabetes & Metabolism|January 9, 1999
[Benefits of blood glucose self-monitoring in the management of insulin-dependent (IDDM) and non-insulin-dependent diabetes (NIDDM). Analysis of the literature: mixed results]S Halimi
Diabetes & Metabolism|July 22, 2008
DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?S Halimi
Annales D'Endocrinologie|May 31, 2002
[Is a new therapeutic class justified in the treatment of type 2 diabetes?]S Halimi
Annales D'Endocrinologie|June 17, 2005
[Editorial]S Halimi
Presse Medicale (Paris, France : 1983)|November 5, 2005
[Primary cardiorenal prevention in patients with type-2 diabetes. The Roadmap study]S Halimi
Diabetes & Metabolism|January 8, 2011
Acute consequences of hypoglycaemia in diabetic patientsS Halimi
Nephrologie|February 24, 2001
[Dyslipidemia of diabetes and insulin resistance]S Halimi
Diabetes & Metabolism|April 23, 2014
Do not forget that type 2 diabetes does not only expose to cardiovascular complicationsS Halimi
Annales D'Endocrinologie|June 17, 2005
[Coming clinical recommendations: where will the glitazones fit in?]S Halimi
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Diabetes & Metabolism|February 14, 2007
Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes managementS Halimi
Diabetes & Metabolism|January 9, 1999
[Benefits of blood glucose self-monitoring in the management of insulin-dependent (IDDM) and non-insulin-dependent diabetes (NIDDM). Analysis of the literature: mixed results]S Halimi
Diabetes & Metabolism|July 22, 2008
DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?S Halimi
Annales D'Endocrinologie|May 31, 2002
[Is a new therapeutic class justified in the treatment of type 2 diabetes?]S Halimi
Annales D'Endocrinologie|June 17, 2005
[Editorial]S Halimi
Presse Medicale (Paris, France : 1983)|November 5, 2005
[Primary cardiorenal prevention in patients with type-2 diabetes. The Roadmap study]S Halimi
Diabetes & Metabolism|January 8, 2011
Acute consequences of hypoglycaemia in diabetic patientsS Halimi
Nephrologie|February 24, 2001
[Dyslipidemia of diabetes and insulin resistance]S Halimi
Diabetes & Metabolism|April 23, 2014
Do not forget that type 2 diabetes does not only expose to cardiovascular complicationsS Halimi
Annales D'Endocrinologie|June 17, 2005
[Coming clinical recommendations: where will the glitazones fit in?]S Halimi
Pageof 15